Greenville Hospital System University Medical Center, (ITOR)

Greenville, South Carolina 29605

1 studies enrolling now · 9 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumor, HPV-Related Squamous Cell Carcinoma, Locally Advanced Rectal Cancer, Locally Advanced/Metastatic Solid Tumors, Oncology, Refractory Non-Hodgkin Lymphoma, Solid Tumor, Solid Tumors, Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction

Studies at this site

• A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors — Recruiting now
• Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors — Recruiting now
• A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers — Completed
• Study of Avelumab-M3814 Combinations — Completed
• MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors — Completed
• Safety Study of BJ-001, an IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid Tumors — Status unconfirmed
• Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer — Completed
• Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) — Completed
• RDEA119 and Sorafenib Combination Dose Escalation Study — Completed